04 July 2025 : Clinical Research
Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
Mehmet Kursat Derici ABCDEF 1*, Engin Yıldırım ABCDEFG 2DOI: 10.12659/MSM.947895
Med Sci Monit 2025; 31:e947895
Table 1 Comparison of clinical and biochemical data of patients with polycystic ovary syndrome and women with unexplained ınfertility.
| Unexplained infertile group (n=55)Mean±Std/Median (min–max) | PCOS group (n=51)Mean±Std/Median (min–max) | P | |
|---|---|---|---|
| Age (years) | 33.2±5.130 (28–38) | 32.2±4.927 (27–36) | 0.101 |
| BMI (kg/m) | 23.8±2.521.8 (17.4–25.3) | 25.1±3.324.4 (17.3–26.0) | 0.248 |
| Glucose (mg/dl) | 77.2±11.281.1 (64.3–111.6) | 83.9±5.779.5 (65.4–103.2) | 0.445 |
| AFC | 8.3±4.49 (6–13) | 12.5±6.114 (6–21) | * |
| Endometrium thickness (mm) | 4.5±3.64.2 (2.3–6.1) | 5.1±2.95.1 (2.9–7.6) | 0.301 |
| PCOS – polycystic ovary syndrome; BMI – body mass index; AFC – antral follicle count. * | |||






